Found: 2
Select item for more details and to access through your institution.
Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE-170 phase 2 trial.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 62, doi. 10.1002/hon.2437_49
- By:
- Publication type:
- Article
PHASE 1B STUDY OF PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA ( RRPMBCL): UPDATED RESULTS FROM THE KEYNOTE-013 TRIAL.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 189, doi. 10.1002/hon.2438_50
- By:
- Publication type:
- Article